Asia Pacific Forced Oscillometry Market Analysis and Forecast by Size, Share, Growth, Trends 2034

Coverage: By Product (Device and Accessories), Device For Product (Desktop and Portable), Accessories For Product (Filters, Nose Clip, Support Arms, and Other Accessories), Application (Asthma, COPD, and Other Applications), and End User (Hospitals and Clinics, Diagnostic Laboratories, and Other End users)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Published
  • Report Code : TIPRE00043873
  • Category : Life Sciences
  • No. of Pages : 156
  • Available Report Formats : pdf-format excel-format
  • Last update date : July 24, 2026
Asia Pacific Forced Oscillometry Market Analysis and Forecast by Size, Share, Growth, Trends 2034
Report Date: July 24, 2026   |   Report Code: TIPRE00043873 Email: sales@theinsightpartners.com

2025 Market Size

US$

Base year value

2034 Forecast

US$

Projected by 2034

CAGR 2026-2034

5.9 %

Growth rate

Addressable Market

US$ 95,170.97 THOUSAND

(2026-2034)

The Asia Pacific Forced Oscillometry Market size is expected to reach US$ 13,075.3 Thousand by 2034 from US$ 7,853.0 Thousand in 2025. The market is estimated to record a CAGR of 5.9% from 2026 to 2034.

Executive Summary and Asia Pacific Forced Oscillometry Market Analysis:

The forced oscillometry market in Asia Pacific is segmented into Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific. The increasing prevalence of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) is common across many Asia Pacific countries due to urbanization, rising pollution levels, and lifestyle changes; this has heightened demand for effective, noninvasive diagnostic tools such as oscillometry that assess lung function during normal breathing without patient effort.

The method's patient-friendly nature-usable in children, the elderly, and individuals unable to perform traditional spirometry-boosts adoption in both clinical and community settings. Advancements in medical technology and the introduction of portable, easy-to-operate oscillometry devices are improving access and utility, encouraging healthcare providers and diagnostic labs to integrate these systems into routine respiratory assessments. Additionally, expanding healthcare infrastructure, increased healthcare spending, and supportive government initiatives in key markets such as China, India, Japan, and Australia are facilitating wider adoption of advanced respiratory monitoring technologies. As awareness about early detection grows among clinicians and patients, demand for oscillometry and related forced oscillation technique solutions is expected to sustain its robust growth in Asia Pacific.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Asia Pacific Forced Oscillometry Market: Strategic Insights

asia-pacific-forced-oscillometry-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Asia Pacific Forced Oscillometry Market Segmentation Analysis:

  • By Product, the Asia Pacific Forced Oscillometry Market is segmented into Device and Accessories. The Device segment dominated the market in 2025.
  • By Device For Product, the Asia Pacific Forced Oscillometry Market is segmented into Desktop and Portable. The Desktop segment dominated the market in 2025.
  • By Accessories For Product, the Asia Pacific Forced Oscillometry Market is segmented into Filters, Nose Clip, Support Arms, and Other Accessories. The Filters segment dominated the market in 2025.
  • By Application, the Asia Pacific Forced Oscillometry Market is segmented into Asthma, COPD, and Other Applications. The Asthma segment dominated the market in 2025.
  • By End User, the Asia Pacific Forced Oscillometry Market is segmented into Hospitals and Clinics, Diagnostic Laboratories, and Other End users. The Hospitals and Clinics segment dominated the market in 2025.

Asia Pacific Forced Oscillometry Market Report Scope

Report Attribute Details
Market size in 2025 US$ 7,853.0 Thousand
Market Size by 2034 US$ 13,075.3 Thousand
CAGR (2026 - 2034) 5.9%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Product
  • Device
  • Accessories
By Device For Product
  • Desktop
  • Portable
By Accessories For Product
  • Filters
  • Nose Clip
  • Support Arms
  • Other Accessories
By Application
  • Asthma
  • COPD
  • Other Applications
Regions and Countries Covered Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
Market leaders and key company profiles
  • COSMED Srl
  • Chest MI Inc
  • Morgan Scientific Inc
  • THORASYS Thoracic Medical Systems Inc.
  • Jaeger Medical GmbH
  • IngMar Medical
  • GANSHORN Medizin Electronic GmbH
  • Lothar Medical GmbH
  • Cognita Labs, LLC
  • RESTECH srl

Asia Pacific Forced Oscillometry Market Players Density: Understanding Its Impact on Business Dynamics

The Asia Pacific Forced Oscillometry Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

asia-pacific-forced-oscillometry-market-cagr

Asia Pacific Forced Oscillometry Market Outlook

Rapid healthcare infrastructure development, growing middle-class health awareness, and escalating chronic respiratory disease burdens position Asia Pacific, Latin America, and parts of Africa as high-potential regions for forced oscillometry adoption. The Global Burden of Disease Study 2017 reported chronic respiratory disease prevalence of 5.5% in South Asia, 7.3% in Latin America and the Caribbean, and 5.1% in sub-Saharan Africa. South Asia recorded the highest years of life lost from these conditions. Modelling from the Global Burden of Disease projects a 23% rise in global COPD cases to ~600 million by 2050, with disproportionately larger increases in low- and middle-income countries and among women, driven by smoking uptake, household and ambient air pollution, and population ageing. Forced oscillometry's effort-independent nature and sensitivity to small-airway dysfunction make it especially suitable for diverse populations in these regions, including children, elderly patients, and individuals with limited literacy or coordination. In India, oscillometry's effort-independent nature aligns with high asthma prevalence, as noted in Karnataka Paediatric Journal reviews emphasizing its role in tidal breathing assessments for underserved populations.

In densely populated urban centers such as Mumbai, India, escalating air pollution from industrial growth and vehicular emissions has led to a surge in respiratory conditions such as asthma and COPD. This creates avenues for FOT device manufacturers to penetrate markets by collaborating with local hospitals and clinics to integrate the technology into routine pulmonary assessments. As primary-care networks expand and public health campaigns raise awareness, portable FOT devices can facilitate early detection and ongoing monitoring in community clinics and outreach programmes, addressing the massive unmet need for accessible, reliable respiratory diagnostics in high-burden, resource-constrained settings.

Asia Pacific Forced Oscillometry Market Country Insights

By country, the Asia Pacific Forced Oscillometry Market is segmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. China held the largest share in 2025.

In China, respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) pose significant health challenges. According to the World Health Organization (WHO) 2023 data, ~100 million people are affected by COPD in the country, accounting for ~25% of all COPD cases worldwide. Furthermore, asthma is a major public health concern in the country. According to "The Epidemiology of Asthma in Mainland China," published in October 2024, the overall prevalence of asthma was 2.20% in the country. High exposure to air pollution, smoking, and biomass fuels contributes to these numbers. Forced oscillometry, a noninvasive technique measuring respiratory impedance during tidal breathing, plays a key role in assessing lung mechanics, particularly for early detection of airway obstruction in these conditions. It requires minimal patient effort, making it suitable for diverse populations, including children and the elderly.

Asia Pacific Forced Oscillometry Market Company Profiles

Some of the key players operating in the market include COSMED Srl, Chest MI Inc, Morgan Scientific Inc, THORASYS Thoracic Medical Systems Inc., Jaeger Medical GmbH, IngMar Medical, GANSHORN Medizin Electronic GmbH, Lothar Medical GmbH, Cognita Labs, LLC, and RESTECH srl.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Asia Pacific Forced Oscillometry Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

  • Company websites, annual reports, financial statements, broker analyses, and investor presentations
  • Industry trade journals and other relevant publications
  • Government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Note:

All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

  • Validate and refine findings from secondary research
  • Enhance the expertise and market understanding of the analysis team
  • Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

  • Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
  • External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA